Blog

New Studies Blue Earth Diagnostics FLC-219: (PDF): An Open-label, Single-arm, Single-dose, Prospective, Multicenter Phase 2b Study to Establish Image Interpretation Criteria for 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases After Radiation Therapy (PURSUE) (NCT04410367) Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A...

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience ( PDF ): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma ( NCT03463265 ) Orbus Therapeutics ( PDF ): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

PNI is proud to announce that we have received the coveted “Team Honor Roll” Award from the North American Skull Base Society (NASBS). The award is granted to institutions with dedicated skull base surgery teams, featuring physicians from various specialties. About the NASBS Team Honor...

In the field of neurosurgery, Daniel F. Kelly, MD, is loved by his patients and esteemed by his colleagues. Soft spoken and eloquent, he has a quiet confidence that underscores this highly skilled neurosurgeon’s drive, determination and focus in always pushing the boundaries of excellence....

A devoted father searching around the world for help finds the care his son needs at Pacific Neuroscience Institute. Read Basab’s story below. A Search for Medical Help and Hope One can only imagine the anguish of Deg Gharti Chhetri by the fall of 2018....

Pacific Rim Master Class in Endoscopic Endonasal and Keyhole Surgery was held at Pacific Neuroscience Institute. The course video playlist is now available.

A former pituitary tumor patient joins forces with the Pacific Pituitary Disorders Center to bring awareness to Cushing's disease and other pituitary tumor-related syndromes. Read about Sharmyn McGraw's 7-year journey.

More than 25 percent of women with Cushing’s disease experienced their first symptoms within one year of giving birth, a small study by researchers at Pacific Neuroscience Institute found.